ELI LILLY & CO (LLY)
Clinical trial NCT07213804 updates: 1. primary completion date: 2028-04-01 → 2028-11-01 2. enrollment: 1080 → 1630 participants
Clinical trial NCT07213804 updates: 1. primary completion date: 2028-04-01 → 2028-11-01 2. enrollment: 1080 → 1630 participants
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical